4MONT M A, CARBONE J J, FAIRBANK A C. Core decompres- sion versus non-oprative management for osteonecrosis of the hip [J]. Clin Orthop Relat Res, 1996,324(3) :169-178.
5SAMUEL J P, NIALL S. Osteonecrosis of the femoral head: Part 2-options for treatment [J]. Curr opin orthop, 2008, 22 (5): 349-358.
6GLUECK C J, FREIBERG R, GLUECK H I, et al teonecrosis, hypo-fibrinolysis, high plasminogen lipoprotein and therapy with stanozolol[J]. AM J Hematol 48(4) : 213-220. C os- high 995,48(4):213-220.
7DISCH A C, MATZIOLIS C,PERKA C. The management of nec rosis associated and idiopathic bone-marrow oedema of the proxi man femur by intravenous iloprost [ J ]. J Bone Joint Surg (Br) 2005,87(4) : 560-564.
8AGRAWALA S,JAIN D,JOSHI V R, et al. Efficacy of alendr- onate,a bisphosphonate, in the treatment of AVN of the hip: A prospective open label study[J]. Rheumatology(Oxford) ,2005,44 (3) :352-359.
9MASSARI L, FINI M, CADOSSI R, et al. Biophysical stimulation with pused electromagnetic fields in osteonecrosis of the femoral head[J]. J Bone Joint Surg(Am) ,2006,88(3):56-60.
10LUDWIG J, LAUBER S, LSUBER H J, et al. High-energy shock wave treatment of femoral head necrosis in adult[J]. Clin Orthop Relat Res,2001, 387(1) :119-126.
